LeMaitre Vascular, Inc. (LMAT) is a publicly traded Healthcare sector company. As of October 12, 2026, LMAT trades at $82.91 with a market cap of $1.85B and a P/E ratio of 27.66. LMAT moved +2.69% today. Year to date, LMAT is +2.23%; over the trailing twelve months it is -3.65%. Its 52-week range spans $71.42 to $118.01. Analyst consensus is buy with an average price target of $97.50. Rallies surfaces LMAT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks LMAT insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $82.91 |
| Market Cap | $1.85B |
| P/E Ratio | 27.66 |
| EPS | $2.89 |
| Dividend Yield | 0.25% |
| 52-Week High | $118.01 |
| 52-Week Low | $71.42 |
| Volume | 209.90K |
| Avg Volume | 0 |
| Revenue (TTM) | $262.43M |
| Net Income | $65.67M |
| Gross Margin | 72.90% |
5 analysts cover LMAT: 0 strong buy, 2 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $97.50.